Is ketorolac appropriate for treating an adult's toothache, and what dosage and contraindications should be considered?

Ketorolac for Toothache

Ketorolac is highly appropriate and effective for treating adult toothache and should be considered a first-line analgesic option, particularly given its superior safety profile compared to opioids. 1

Evidence Supporting Ketorolac Use

The most recent evidence-based guidelines from 2025 establish that NSAIDs, including ketorolac, are first-line therapy for managing acute dental pain when not contraindicated, providing superior pain relief with a more favorable safety profile compared to opioids 1. This represents the strongest current recommendation for dental pain management.

Efficacy in Dental Pain

• Ketorolac demonstrates excellent analgesic efficacy for dental pain, with studies showing it provides pain relief comparable to or better than opioid combinations 2, 3
• In multiple-dose studies of post-extraction dental pain, ketorolac 10-20 mg resulted in only 5.7-31.9% of patients requiring rescue medication, compared to 50.4-80.4% in placebo groups 2
• Ketorolac is effective for both post-extraction pain and acute toothache (irreversible pulpitis), though it works better when combined with appropriate local anesthesia for procedural pain 4, 5

Dosing Recommendations

For acute toothache in adults, the appropriate ketorolac dosing is:

• Oral formulation: 10 mg every 4-6 hours as needed, not exceeding 40 mg/day 6
• Intramuscular formulation: 30 mg as a single dose provides effective immediate relief 7
• Maximum treatment duration: 5 days for combined IV/IM and oral use 6

Important dosing adjustments:

• Patients ≥65 years, renally impaired, or <50 kg: 10 mg once, then 10 mg every 4-6 hours, not exceeding 40 mg/day 6
• Lower doses (10-20 mg) are probably as effective as higher doses (≥30 mg) for acute pain relief 8

Critical Contraindications and Safety Concerns

Ketorolac must be avoided in patients with:

• Active or history of peptic ulcer disease or gastrointestinal bleeding 9, 10
• Aspirin/NSAID-induced asthma 9
• Renal impairment (use with extreme caution; contraindicated in severe renal disease) 9, 6
• Bleeding disorders or thrombocytopenia 9
• Pregnancy, particularly third trimester 9
• Cerebrovascular hemorrhage 9
• Age <17 years for oral formulation 6

High-Risk Populations Requiring Caution

Patients at increased risk for NSAID toxicity include: 9

• Age ≥60 years (increased GI and renal toxicity risk)
• Cardiovascular disease or risk factors (NSAIDs can worsen hypertension)
• Concurrent anticoagulant use (significantly increases bleeding risk)
• Hepatic dysfunction
• Concurrent nephrotoxic chemotherapy or medications

Practical Clinical Algorithm

Step 1: Screen for contraindications

• Review patient history for GI bleeding, renal disease, bleeding disorders, NSAID allergy
• Check age, weight, and current medications (especially anticoagulants)

Step 2: Determine appropriate formulation and dose

• For immediate relief: Consider IM ketorolac 30 mg (if age 17-64, normal renal function, >50 kg) 7
• For ongoing management: Oral ketorolac 10 mg every 4-6 hours 6
• Adjust to 10 mg dosing for elderly, low weight, or mild renal impairment 6

Step 3: Set treatment duration limits

• Never exceed 5 days total treatment 6
• Plan definitive dental treatment within this window
• Consider transitioning to other NSAIDs (ibuprofen 400-800 mg) for longer-term needs 9

Step 4: Monitor for adverse effects

• GI upset, bleeding, or black stools
• Worsening hypertension
• Decreased urine output or edema
• Dizziness or drowsiness 9

Comparative Effectiveness

Ketorolac versus opioids:

• Effect size analysis shows ketorolac nasal spray (31.5 mg) has similar or superior pain relief compared to hydrocodone/acetaminophen and oxycodone/acetaminophen combinations 3
• Ketorolac avoids opioid-related risks including respiratory depression, nausea, constipation, and addiction potential 1

Ketorolac versus other NSAIDs:

• Ketorolac 10-20 mg is more efficacious than ketoprofen 50 mg for dental pain 2
• Injectable ketorolac provides equivalent pain relief to oral formulations but with faster onset 5

Common Pitfalls to Avoid

1. Do not exceed 5-day treatment duration - this is the most critical safety limit to prevent serious GI and renal complications 6, 10
2. Do not use oral ketorolac as initial dose - it should only follow IV/IM dosing in adults 6
3. Do not assume higher doses are better - 10-20 mg is probably as effective as 30 mg with potentially fewer adverse effects 8
4. Do not ignore age and weight adjustments - elderly and low-weight patients require reduced dosing 6
5. Do not combine with other NSAIDs - this increases toxicity risk without improving efficacy 9

Special Considerations for ICU/Hospital Settings

In critically ill patients requiring pain management, ketorolac has advantages over opioids including no respiratory depression, no effect on gastric motility, and no sedation 9. However, reduced doses are essential with renal dysfunction, and the drug should be avoided in patients at high risk for bleeding or with peptic ulcer disease 9.